Pineal gland in autoimmunity: melatonin-dependent exaggeration of collagen-induced arthritis in mice.
Explore the source record for details and available documents.
Animals↗
Biomedical subjects
R Mattsson
Publications and source records attributed to R Mattsson.
Induction of mouse tenascin expression by a human sarcomatoid Wilms' tumor cell line growing in nude mice.
A new cell line from a sporadic Wilms' tumor was established and extensively characterized. In nude mice, the tumor cells rapidly formed tumors which, in histological characteristics and extracellular-matrix (ECM) composition resembled sarcomatoid Wilms' tumor. The tumor cells produced B chains of laminin, but no A chain, and laminin was deposited into the ECM in a punctate pattern typical of sarcomatoid tumors. Strong expression of tenascin was detected within the stromal ECM of the tumors. Species-specific antibodies reacting either with human or with mouse tenascin showed that tenascin was exclusively derived from mouse host cells. The human Wilms' cell line thus induced a strong stromal response with increased deposition of tenascin. The cell line may be useful for studying the behavior of sarcomatoid Wilms' tumor cells and for identifying factors that stimulate synthesis of tenascin.
Animals↗
Pinealectomy ameliorates collagen II-induced arthritis in mice.
To extend our previous findings that exposure to constant darkness (stimulation of endogenous melatonin release) as well as treatment with exogenous melatonin magnifies the severity of collagen-induced arthritis in mice, we have examined the effects of melatonin cutback by removing the pineal gland. Two strains of mice, DBA/1 and NFR/N, were subjected to surgical pinealectomy. The melatonin levels in sera were reduced by approximately 70% by the pinealectomy compared with the corresponding sham-operated controls. After 3-4 weeks of rest the mice were immunized with rat type II collagen to induce autoimmune arthritis, and the animals were kept in constant darkness during the experiments. In comparison with the controls, all groups of pinealectomized mice showed reduced severity of the arthritis by means of (i) a slower onset of the disease, (ii) a less severe course of the disease (reduced clinical scores), and (iii) reduced serum levels of anti-collagen II antibodies. These effects were not significant in all experiments, but the trends were always the same. Thus, the present result strengthen the hypothesis that high physiological levels of melatonin (which can be induced by exposure to darkness) stimulate the immune system and cause exacerbation of autoimmune collagen II arthritis, while inhibition of melatonin release (pinealectomy or exposure to light) has a beneficial effect.
Animals↗
Identification and classification of different isolates of Francisella tularensis.
The causative agent of tularemia, Francisella tularensis, occurs in two main biovars, the highly virulent F. t. biovar tularensis, found in North America; and the less virulent biovar palaearctica, found all over the northern hemisphere. Two other biovars have been proposed, F. t. biovar mediaasiatica and F. t. biovar palaearctica var. japonica. In Sweden tularemia is most frequently observed in man and varying hares (Lepus timidus), and occasionally in other species. Tularemia in hares is normally an acute fatal disease, although less fatal infections have been reported. The diagnosis of tularemia is routinely based on immunological reactions. We studied 10 different isolates of F. tularensis from varying hares, one isolate from an Ural owl (Strix uralensis), one vaccine strain, one strain of F. t. biovar japonica, and six isolates from a virulence study of F. tularensis, by biochemical tests and by hybridization experiments with probes complementary to 16S rRNA. All isolates, except the isolate F. t. biovar japonica, were characterized as F. t. biovar palaearctica by biochemical tests. In the 16S rRNA analysis all isolates were positive to the probe for Francisella tularensis and the probe for F. t. biovar palaearctica with the exception that F. t. biovar japonica reacted with the probe specific to F. t. biovar tularensis. To further confirm that the strains used belonged to F. t. biovar palaearctica virulence tests in rabbits were performed which disclosed this phenotype. The results presented in this work show that the isolated strains from the western part of Europe were F. t. biovar palaearctica, irrespective of animal origin or virulence.
Animals↗
A fraction of murine placental extract enhances IgA production in cultured splenocytes.
During the second half of murine pregnancy there is a characteristic increase in the number of spontaneous immunoglobulin-secreting cells in the maternal spleen (IgM, IgG and IgA), the uterus-draining lymph nodes (IgG) and Peyer's patches (IgA). There are indications that signals originating from the feto-placental unit are of importance for the generation of at least some of these changes. To evaluate further the role of placental factors as regulators of maternal Ig-secretion, placental extract (PE) was separated into eight fractions by gel-chromatography and each fraction was screened for its effect on splenic (1) background DNA-synthesis, (2) background Ig-secretion and (3) Ig-secretion in lipopolysaccharide (LPS) activated B-cells (anti-Thy1.2 + complement-treated splenocytes). Similarly prepared extracts of fetuses, maternal spleen and maternal liver served as controls. All tissue extracts and splenocytes were syngeneic to avoid reaction to allogeneic determinants. Placental extract fractions did not differ significantly from the other tissue extracts in affecting background lymphocyte activity. However, fraction number 3 from placental extract (PE3, corresponding to an approximate molecular weight of 18-70 kDa) was found strongly to increase the number of IgA-secreting cells (P less than or equal to 0.001) in LPS-activated B-cells. This effect was absent or much less pronounced in the corresponding controls. Blocking of PE3-activity by antibodies against rat prolactin indicated that the enhancing activity may be attributed to proteins of the prolactin/placental lactogen/growth hormone family. This assumption was further strengthened by experiments demonstrating that prolactin exerted preferential enhancement of IgA secretion when added to LPS-activated B-cell cultures in vitro. The possible role of placental prolactin-like molecules as regulators of maternal IgA secretion is discussed.
Animals↗
The pineal hormone melatonin exaggerates development of collagen-induced arthritis in mice.
We have previously shown that constant darkness enhances autoimmunity to type II collagen (CII) and exaggerates development of collagen-induced arthritis (CIA) in DBA/1 mice. This effect was suggested to be mediated via the major hormone of the pineal gland, melatonin, since this hormone (1) is known to be strongly dependent on environmental lighting and (2) has been reported to affect the immune function. The present study was performed in order to clarify if melatonin could account for the previous observation that mice kept in darkness had a more pronounced development of CIA. First, DBA/1 mice kept in constant darkness were analysed for serum melatonin levels. An increase in background levels in comparison to mice kept in a normal dark/light cycle or in constant light was recorded. Then, different groups of mice (kept in constant light in order to minimize endogenous melatonin levels) were immunised with rat CII to induce arthritis and injected with melatonin. Melatonin injections were performed daily (1 mg/kg b.w.) in the afternoons (at 4 p.m.) for 10 days at two different periods: day 1-10 after collagen injection, or at the onset of the disease (day 30-39). Mice injected with melatonin at day 1-10 developed a more severe arthritis while those injected at onset did not differ significantly from the corresponding controls. Our results support the hypothesis that the pineal gland can exaggerate the development of CIA via a high release of melatonin, probably via enhancement of T-cell priming.
Animals↗
Progress in veterinary mycology.
Explore the source record for details and available documents.
Animals↗
In vivo treatment with interferon-gamma during early pregnancy in mice induces strong expression of major histocompatibility complex class I and II molecules in uterus and decidua but not in extra-embryonic tissues.
Allopregnant (NFR/N [Swiss-derived] H-2q females x 57/Bl H-2b males) and syngeneically pregnant (NFR/N x NFR/N) mice were subjected to daily injections (10(5) U/mouse/day, from Day 5.5 of gestation) of recombinant rat or mouse interferon-gamma (IFNg) in order to investigate its ability to induce extra-embryonic major histocompatibility complex (MHC) expression and antipaternal immune reactions if administered during the first part of the gestation period. In addition, a limited number of IFNg-treated embryo-transferred NFR/N mice carrying C57/B1 embryos (representing a complete allogenic pregnancy) were investigated. Mouse and rat IFNg caused the same type of histological and physiological changes, and most of the experiments were performed by using rat IFNg. Several IFNg-treated mice (irrespective of type of mating) showed a drop in weight and a high rate of resorptions at Day 12.5 of gestation. This interference with pregnancy appeared not to be caused by immunological reactions against the feto-placental unit (no leukocyte infiltration and no significant effect on serum levels of antipaternal antibodies in preimmunized allopregnant IFNg-treated mice). Immunohistochemical stainings of cryosectioned tissues at Day 9.5 of pregnancy revealed that IFNg treatment caused a strong induction of MHC class I and class II expression on most cells in the uterus and on several cells in the maternal decidua, while there was a complete absence of detectable MHC class I and class II expression in the extra-embryonic tissues. Characteristic for a Day 12.5 placenta of an IFNg-treated mouse (including embryo-transferred mice) was a strongly MHC class II-induced maternal decidua and a completely MHC class II-negative fetal placenta. The pattern of IFN-induced MHC class I expression was similar to that of class II, with the exception of class I expression on scattered cells within the basal zone. Thus, the present study provides immunohistological evidence that IFNg administered in vivo during the first part of gestation is not capable of inducing MHC expression on murine extra-embryonic cells despite an extremely high expression of MHC molecules on decidual cells in intimate contact with extra-embryonic tissues. It is likely that the resistance to IFNg-mediated induction of MHC expression on extra-embryonic cells is of basic importance for the protection of mammalian semi-allogeneic fetuses.
Animals↗
Increased levels of prolactin during, but not after, the immunisation with rat collagen II enhances the course of arthritis in DBA/1 mice.
In addition to its well known effects on reproductive organs and lactation the pituitary hormone prolactin (PRL) also influences immune functions. The present investigation was performed in order to clarify the regulatory role of prolactin in autoimmune disease by using the collagen II arthritis model. Groups of virgin female DBA/1 mice were subjected to different short-term treatment protocols (5-10 days) with rat PRL and the drugs bromocriptine (inhibits prolactin secretion) and haloperidol (enhances prolactin secretion). Treatments were performed at different stages of disease development, and effects on clinical scores, anti-collagen II antibody titres as well as agalactosyl IgG levels were recorded. The effects of the treatment protocols on serum PRL levels were assessed by using a radioimmunoassay (RIA) system. Although the accumulated results of the present study indicate that PRL does not fulfil a major role in the regulation of collagen II arthritis, some interesting observations were made. High levels of PRL (PRL injections) made the arthritis worse only if treatment was performed during the induction stage of the disease. Bromocriptine treatment during the immunisation period did not significantly affect the course of arthritis, but treatment at later stages tended to cause exacerbation (significant at the onset period only). These results indicate that PRL has different effects during early and late stages of the development of collagen II-induced arthritis.
Animals↗
Placental MHC class I antigen expression is induced in mice following in vivo treatment with recombinant interferon-gamma.
Allogeneically pregnant mice (NFR/N (Swiss-derived) H2q x 57/B1 H2b) were injected daily from day 11 to 18 of gestation with recombinant rat interferon-gamma (IFN-gamma) and the effects on placental MHC antigen expression were evaluated by immunohistochemistry. The results demonstrated that a daily dose of 200,000 U/mouse induces a significant increase in placental MHC class I expression in the decidua and the basal zone spongiotrophoblast as well as the fetal mesenchyme, while the labyrinthine trophoblast was almost completely MHC negative. No significant induction of MHC class II antigen expression was observed in the placental tissue, with the exception of a few scattered cells. The MHC class II-inducing efficiency of the treatment protocol used was ascertained by staining maternal skin (ear), which proved to contain considerably elevated numbers of MHC class II-positive cells (mainly keratinocytes). The IFN-gamma treated group showed a higher incidence of fetal resorptions than the corresponding controls, but this was probably due to a non-specific toxic effect of the treatment as none of the sera analysed contained detectable amounts of anti-paternal antibodies, no infiltrating lymphocytes were detectable on histological examination of placental sections, and most of the IFN-gamma treated animals successfully completed their pregnancy.
Animals↗
Maintained pregnancy levels of oestrogen afford complete protection from post-partum exacerbation of collagen-induced arthritis.
Pregnancy is known to influence the course of rheumatoid arthritis (RA) in women, as well as type II collagen-induced arthritis (CIA) in DBA/1 mice. A characteristic feature is the remission during gestation and the exacerbation of the diseases during the post-partum period. In the case of CIA in DBA 1 mice, two hormonal changes have been assumed to be critical for the induction of the post-partum flare: (i) the fall in steroid hormone levels from those present during pregnancy; and (ii) surges of prolactin (PRL) release at and after delivery. Our results show that treatment with oestradiol during a short period immediately after parturition protects the mouse from a post-partum flare of the disease, and that treatment with bromocriptine, a drug known to inhibit the endogenous PRL release, has a significant though less marked effect. Studies of lactating (i.e. animals with physiological stimulation of endogenous PRL release) and non-lactating arthritic mice revealed no clear-cut differences, indicating that PRL is of minor importance for the induction of the post-partum flare. Some steroids other than oestradiol, which may be implicated in the exacerbation of arthritis, namely progesterone and hydrocortisone, had no clinical effect. Analyses of agalactosyl IgG levels in mice with CIA, and anti-collagen II antibodies in sera collected at the end of the experiments revealed no significant differences between the oestradiol and the control groups. The successful oestradiol treatment of the mice indicates that the drop in endogenous oestradiol levels prior to delivery ends the oestrogen-mediated protection against arthritis during pregnancy.
Animals↗
Humoral immune activity in CBA/Ca mice during late pregnancy and the post-partum period.
Syngeneically mated CBA/Ca mice were used to measure "spontaneous" immunoglobulin (Ig) secretion in the Peyer's patches (PP), spleen and the para-aortic lymph nodes (PALN), employing a protein A plaque assay, during the latter part of pregnancy and in the post-partum period. The lactating and non-lactating females were compared with respect to humoral immune activity (plaque-forming cells) and serum Ig levels (ELISA technique). The pregnancy-induced weight changes in some lymphoid organs and the elevation in the number of plaque-forming cells in spleen (IgG and IgM PFC), PALN (IgG and IgM PFC) and the PP (IgA PFC) lasted longer in the lactating than in the non-lactating mice (owing to hormonal differences). A very strong decrease in serum IgG was observed during pregnancy and after parturition IgG levels remained depressed longer in lactating than in non-lactating mice. Interest has been focused on IgA in the study and this has been discussed as well as the possible reasons for the increased turnover of maternal serum Ig (especially IgG).
Animals↗
Constant darkness enhances autoimmunity to type II collagen and exaggerates development of collagen-induced arthritis in DBA/1 mice.
The humoral function of the pineal gland is known to be strongly dependent on environmental lighting. Melatonin, the best characterized of the photo-dependent pineal hormones, has been reported to affect immune responses in mice. It has been hypothesized that the development of some types of psychosomatic and autoimmune diseases could be due to a disturbed release of this hormone. The present investigation was performed in order to evaluate effects of constant darkness (physiological stimulation of pineal melatonin synthesis) and constant light (physiological suppression of pineal melatonin synthesis) on the course of an experimental autoimmune model, the type II collagen-induced arthritis (CIA) in DBA/1 female mice. Mice kept in darkness develop more severe arthritis than those kept in constant light or in a normal dark/light rhythm (12 h light/12 h dark). Levels of anti-type II collagen antibodies were higher in mice kept in darkness, and the spleens of these animals were enlarged. Since castration of female DBA/1 mice enhances the severity of CIA, and since melatonin is known to exert effects on gonadal function, the experiment was repeated using oophorectomized mice. The same difference in arthritis severity between darkness- and light-exposed mice was obtained in this second experiment. We conclude that the exacerbation of arthritis in darkness is due to a darkness-induced change in levels of critical neurohumoral compound(s), that via gonadal independent mechanisms affect the autoimmune response. The exaggerated severity and chronicity of arthritis may be due to higher levels of melatonin in these animals.
Animals↗
Estrogen induced suppression of collagen arthritis. V: Physiological level of estrogen in DBA/1 mice is therapeutic on established arthritis, suppresses anti-type II collagen T-cell dependent immunity and stimulates polyclonal B-cell activity.
Immunization of castrated female DBA/1 mice with rat type II collagen (CII) induces severe polyarthritis with an onset 3-5 weeks after immunization and with 80-100% incidence. Estrogen treatment, inducing physiological 17 beta-estradiol (E2) levels, during a limited period before and after the immunization, or during another period before the expected onset of arthritis, delayed the arthritic onset by approximately 10 days but did not affect the incidence of severity of arthritis. Treatment with physiological doses of E2 after onset of arthritis decreased severity and duration of disease. The T-cell dependent anti-CII autoantibody response was suppressed if the E2 treatment was given immediately before and after CII immunization and was not significantly affected if E2 treatment was given after CII immunization. Neither the total anti-CII Ig levels nor the anti-CII IgG2a levels correlated with development of arthritis. We also titrated the serum levels of estrogen and recorded the vaginal smear response after injections of various doses of E2. This enabled us to work in a physiological range of estrogen levels, spanning the levels found at the end of pregnancy and those found during the normal estrous cycle. These levels were found to suppress antigen-specific T-cell functions but enhance certain B-cell activities since the delayed type hypersensitivity (DTH) reaction against CII was suppressed while the total number of splenic Ig-secreting cells increased. These findings suggest that estrogen in physiological doses is therapeutic for the development of collagen-induced arthritis and that estrogen exerts dualistic effects on the immune system by suppressing T-cell functions and stimulating certain B-cell activities. The suppressive effect on arthritis could not be explained by suppression of anti-CII autoantibody response and must therefore depend on other T-cell-mediated functions.
Analysis of Variance↗
Expression of a cell surface antigen with potential Ca2+-sensor/receptor function in rat placenta and uterus.
The reactivities of monoclonal anti-parathyroid antibodies identifying a cell surface 'calcium sensing' mechanism were investigated in the placenta and uterus of the pregnant rat. The rat placenta showed positively stained cells at the end of pregnancy. Staining was confined exclusively to the columnar epithelial cells lining the sinuses of Duval. In the uterus, positive staining of the epithelium lining the uterine lumen was obtained exclusively prior to and during implantation.
Animals↗
Allopregnancy in B-cell deprived C57/BL mice--an investigation focusing on the relationship between survival of the fetuses and anti-paternal immune activity of the mothers.
C57/B1 female mice (haplotype H2-b) were treated throughout their life cycles with rabbit anti-mouse IgM antibodies in order to remove all maturing B-lymphocytes. At an age of 40 days the B-cell-deprived mice and the corresponding controls were allowed to mate with CBA/Ca males (haplotype H2-k). Four groups of allopregnant animals were investigated: (A) mice not subjected to further treatment, which were allowed to pass through a first pregnancy, (B) mice not subjected to further treatment, which were allowed to pass through a first and second pregnancy, (C) mice immunized with paternal cells prior to mating and then allowed to pass through a first pregnancy, (D) mice which during their first pregnancy were given transfusions of anti-paternal lymphocytes obtained from hyperimmune virgin donors. All animals were dissected on the calculated day for parturition (or the first day that abortions or resorptions were detected). On conclusion of the experiments, the efficiency of the anti-IgM treatment was defined for each mouse, using three different methods (ELISA for detection of serum IgG, immune staining for detection of surface Ig-carrying cells, and the protein A plaque assay for detection of Ig-secreting cells). The T-cell function was recorded in vitro by ConA responsiveness. In addition, control animals were assayed for anti-paternal serum antibodies. In experiments (A), (B) and (C), B-cell-deprived mice and corresponding controls were equally successful in passing through pregnancy, having fairly similar litter sizes and resorption frequency. In group (D), however, some of the anti-IgM-treated mice resorbed all her fetuses. Those that gave birth at on schedule had a resorption frequency and litter size fairly similar to those of the controls.
Animals↗
Enhancement of murine splenic immunoglobulin secretion in vitro by supernatants from fetal and placental cell cultures.
Supernatants from short-term cell cultures of fetal and placental tissues of mid-term allogeneically (CBA/Ca x C57/Bl) and syngeneically (CBA/Ca x CBA/Ca) pregnant mice were tested for B-cell enhancing activity in vitro. Immunoglobulin (Ig) secreting cells were detected by the protein-A-plaque assay and DNA synthesis was measured by the incorporation of [3H]thymidine. Supernatants from placental and fetal liver cell cultures (but not fetal fibroblasts) were significantly stimulatory to spontaneous IgM (and to some extent IgG) production in a system using adult untreated spleen cells as target cells. Conditioned media were also added to LPS- and PHA-activated spleen cell cultures. In this system none of the supernatants affected the development of Ig secretors. The DNA synthesis of the target cells was slightly depressed by the addition of conditioned medium from fetal and placental cells. The results indicate that the typical increase in the number of maternal splenic Ig secretors observed in vivo during murine pregnancy could be the result of enhancing factors deriving from the placenta and the fetus (e.g. fetal liver).
Animals↗
An investigation of allogeneic pregnancy in multiparous mice subjected to in vivo depletion of CD8 (Ly2)-positive lymphocytes by monoclonal antibody treatment.
Adult thymectomized C57/Bl (H-2b) and DBA/1 (H-2q) female mice were subjected to treatment with rat anti-mouse CD8 and mouse anti-rat Ig (kappa) prior to entering their third pregnancy with CBA/Ca (H-2k) males. The treatment protocol drastically reduced the number of CD8 (Ly2)-carrying lymphocytes (T-cytotoxic/suppressor phenotype) in the spleen and para-aortic lymph nodes, as assessed by immuno-staining. All mice were investigated on day 18 of their third gestation. The following data were collected from experimental and control groups: (1) resorption frequency, (2) weight of the placenta, fetuses, spleen and para-aortic lymph nodes, (3) immunohistochemical analysis of maternal lymphoid tissues, (4) level of anti-paternal IgG serum antibodies, (5) content of "background" IgM and IgG-secreting cells in spleen and para-aortic lymph nodes. Neither the resorption frequency nor placental/fetal weight was affected by anti-CD8 treatment. However, the formation of anti-paternal antibodies was enhanced in anti-CD8 treated C57/Bl mice.
Animals↗